Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Payers' Guide
Drug Updates
,
FDA Approvals
,
Payers' Guide
Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma
Lisa A. Raedler, PhD, RPh
Play Video
Drug Updates
,
FDA Approvals
,
Payers' Guide
Entresto (Sacubitril/Valsartan): First-in-Class Angiotensin Receptor Neprilysin Inhibitor FDA Approved for Heart Failure
Loretta Fala
Play Video
Select Drug Profiles
,
Payers' Guide
Erleada (Apalutamide) First Drug Approved by the FDA for Nonmetastatic Castration-Resistant Prostate Cancer
Loretta Fala
Play Video
Select Drug Profiles
,
Payers' Guide
Eylea (Aflibercept) Receives FDA Approval of New Dose for Age-Related Macular Degeneration
Lisa A. Raedler, PhD, RPh
Play Video
Drug Updates
,
FDA Approvals
,
Payers' Guide
Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma
Lisa A. Raedler, PhD, RPh
Play Video
FDA Approvals
,
Payers' Guide
FDA Approvals in 2017 Represent a 21-Year High
Gary M. Owens, MD
Play Video
FDA Approvals
,
Drug Updates
,
Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2012
Play Video
Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2013
Play Video
Drug Updates
,
Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2014
Play Video
Drug Updates
,
FDA Approvals
,
Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2015
Play Video
1
2
3
4
5
6
7
Page 4 of 19
Results 31 - 40 of 185